san 202791 has been researched along with nimodipine in 3 studies
| Studies (san 202791) | Trials (san 202791) | Recent Studies (post-2010) (san 202791) | Studies (nimodipine) | Trials (nimodipine) | Recent Studies (post-2010) (nimodipine) |
|---|---|---|---|---|---|
| 31 | 0 | 2 | 2,936 | 317 | 597 |
| Protein | Taxonomy | san 202791 (IC50) | nimodipine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 0.11 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.19 | |
| Cannabinoid receptor 1 | Homo sapiens (human) | 1.736 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 3.38 | |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Homo sapiens (human) | 0.0298 | |
| Voltage-dependent L-type calcium channel subunit beta-2 | Homo sapiens (human) | 0.0298 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 7.15 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 0.0699 | |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Homo sapiens (human) | 1.243 | |
| Bile acid receptor | Homo sapiens (human) | 8.96 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolger, GT; O'Neill, SK | 1 |
| Dannies, PS; Law, GJ; Pachter, JA | 1 |
| Brown, AM; Childs, GV; Marchetti, C | 1 |
3 other study(ies) available for san 202791 and nimodipine
| Article | Year |
|---|---|
The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amlodipine; Animals; Anticonvulsants; Calcium Channel Agonists; Calcium Channel Blockers; Dihydropyridines; Male; Mice; Nifedipine; Nimodipine; Seizures | 1990 |
Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Radioisotopes; Dihydropyridines; Female; In Vitro Techniques; Inositol Phosphates; Nimodipine; Perfusion; Prolactin; Pyridines; Rats; Rats, Inbred Strains; Receptors, Purinergic; Thyrotropin-Releasing Hormone | 1991 |
Involvement of sodium channels and two types of calcium channels in the regulation of adrenocorticotropin release.
Topics: Adrenocorticotropic Hormone; Animals; Cadmium; Cadmium Chloride; Calcium; Calcium Channel Blockers; Corticotropin-Releasing Hormone; Dihydropyridines; Egtazic Acid; Female; Ion Channels; Male; Nimodipine; Pituitary Gland, Anterior; Pyridines; Rats; Rats, Inbred Strains; Sodium; Tetrodotoxin | 1987 |